Integrative Bioinformatics Analysis Revealed Mitochondrial Defects Underlying Hypoplastic Left Heart Syndrome

Diming Zhao1, Yilin Liu2, Zhenqiang Xu3,4

  • 1Department of Cardiovascular Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.

Insights

This study reveals key mitochondrial genes and pathways involved in heart failure in hypoplastic left heart syndrome (HLHS). Findings offer insights into disease mechanisms and potential therapeutic targets for HLHS.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • Bioinformatics

Background:

  • Hypoplastic left heart syndrome (HLHS) is a complex congenital heart defect with poorly understood heart failure mechanisms.
  • Identifying the molecular underpinnings of heart failure in HLHS is crucial for improving patient outcomes.

Purpose of the Study:

  • To elucidate the genetic and molecular mechanisms driving heart failure in hypoplastic left heart syndrome (HLHS).
  • To identify key genes, regulatory pathways, transcription factors (TFs), and microRNAs (miRNAs) associated with heart failure in HLHS.

Main Methods:

  • Integrative bioinformatics analysis of microarray dataset GSE23959.
  • Identification of differentially expressed genes (DEGs) and functional enrichment analysis (GO, KEGG).
  • Construction and analysis of protein-protein interaction (PPI) networks and integrated TF-DEG and miRNA-DEG networks.

Main Results:

  • 210 DEGs were identified, with enrichment analysis highlighting mitochondrial dysfunction.
  • 15 hub genes, including NDUFB6 and ATP5H, were identified, emphasizing mitochondrial components and functions.
  • Key TFs (e.g., NFKB1, RELA) and miRNAs (e.g., hsa-miR-155-5p) were detected, suggesting NF-κB pathway involvement.

Conclusions:

  • Integrative bioinformatics analysis successfully identified mitochondrial-related factors in HLHS-associated heart failure.
  • This study enhances understanding of HLHS pathogenesis and points to novel therapeutic targets.
  • Mitochondrial dysfunction and associated regulatory networks are central to heart failure in HLHS.
Abstract